GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,627,000 | +111.8% | 24,250 | 0.0% | 0.01% | +150.0% |
| Q2 2022 | $768,000 | -9.4% | 24,250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $848,000 | +28.7% | 24,250 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $659,000 | +20.3% | 22,050 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $548,000 | -20.1% | 21,450 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $686,000 | -20.6% | 21,450 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $864,000 | -7.9% | 21,450 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $938,000 | -21.8% | 21,450 | -4.9% | 0.00% | -20.0% |
| Q3 2020 | $1,200,000 | -22.3% | 22,550 | -21.2% | 0.01% | -37.5% |
| Q2 2019 | $1,544,000 | +80.0% | 28,600 | +63.4% | 0.01% | +60.0% |
| Q1 2019 | $858,000 | +50.3% | 17,500 | +22.4% | 0.01% | +25.0% |
| Q4 2018 | $571,000 | -33.4% | 14,300 | -18.3% | 0.00% | -20.0% |
| Q3 2018 | $858,000 | +0.5% | 17,500 | -2.8% | 0.01% | -16.7% |
| Q2 2018 | $854,000 | -0.6% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $859,000 | +305.2% | 18,000 | +143.2% | 0.01% | +200.0% |
| Q4 2017 | $212,000 | 0.0% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $212,000 | +0.5% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $211,000 | – | 7,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |